Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.
Pectasides D, Aravantinos G, Kalofonos H, Kiamouris C, Bafaloukos D, Xiros N, Nicolaides C, Visvikis A, Dimopoulos MA. Pectasides D, et al. Among authors: xiros n. Ann Oncol. 2001 Oct;12(10):1417-22. doi: 10.1023/a:1012599307090. Ann Oncol. 2001. PMID: 11762814 Free article. Clinical Trial.
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group.
Bamias A, Aravantinos G, Deliveliotis C, Bafaloukos D, Kalofonos C, Xiros N, Zervas A, Mitropoulos D, Samantas E, Pectasides D, Papakostas P, Gika D, Kourousis C, Koutras A, Papadimitriou C, Bamias C, Kosmidis P, Dimopoulos MA; Hellenic Cooperative Oncology Group. Bamias A, et al. Among authors: xiros n. J Clin Oncol. 2004 Jan 15;22(2):220-8. doi: 10.1200/JCO.2004.02.152. Epub 2003 Dec 9. J Clin Oncol. 2004. PMID: 14665607 Clinical Trial.
Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial.
Pectasides D, Pectasides M, Farmakis D, Kostopoulou V, Nikolaou M, Gaglia A, Koumpou M, Mylonakis N, Xiros N, Economopoulos T, Raptis SA. Pectasides D, et al. Among authors: xiros n. Ann Oncol. 2005 Feb;16(2):294-9. doi: 10.1093/annonc/mdi053. Ann Oncol. 2005. PMID: 15668287 Free article. Clinical Trial.
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
Xiros N, Papacostas P, Economopoulos T, Samelis G, Efstathiou E, Kastritis E, Kalofonos H, Onyenadum A, Skarlos D, Bamias A, Gogas H, Bafaloukos D, Samantas E, Kosmidis P. Xiros N, et al. Ann Oncol. 2005 May;16(5):773-9. doi: 10.1093/annonc/mdi160. Epub 2005 Mar 31. Ann Oncol. 2005. PMID: 15802284 Free article. Clinical Trial.
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Briasoulis E, Fountzilas G, Bamias A, Dimopoulos MA, Xiros N, Aravantinos G, Samantas E, Kalofonos H, Makatsoris T, Mylonakis N, Papakostas P, Skarlos D, Varthalitis I, Pavlidis N. Briasoulis E, et al. Among authors: xiros n. Cancer Chemother Pharmacol. 2008 Jul;62(2):277-84. doi: 10.1007/s00280-007-0604-7. Epub 2007 Sep 28. Cancer Chemother Pharmacol. 2008. PMID: 17901952 Clinical Trial.
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA. Kosmidis PA, et al. Among authors: xiros n. Ann Oncol. 2008 Jan;19(1):115-22. doi: 10.1093/annonc/mdm430. Epub 2007 Oct 15. Ann Oncol. 2008. PMID: 17938425 Free article. Clinical Trial.
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Fountzilas G, Dafni U, Gogas H, Linardou H, Kalofonos HP, Briasoulis E, Pectasides D, Samantas E, Bafaloukos D, Stathopoulos GP, Karina M, Papadimitriou C, Skarlos D, Pisanidis N, Papakostas P, Markopoulos C, Tzorakoeleftherakis E, Dimitrakakis K, Makrantonakis P, Xiros N, Polichronis A, Varthalitis I, Karanikiotis C, Dimopoulos AM; Hellenic Cooperative Oncology Group. Fountzilas G, et al. Among authors: xiros n. Ann Oncol. 2008 May;19(5):853-60. doi: 10.1093/annonc/mdm539. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042835 Free article. Clinical Trial.
Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.
Pectasides D, Xiros N, Papaxoinis G, Aravantinos G, Sykiotis C, Pectasides E, Psyrri A, Koumarianou A, Gaglia A, Gouveris P, Economopoulos T. Pectasides D, et al. Among authors: xiros n. Gynecol Oncol. 2008 Jan;108(1):47-52. doi: 10.1016/j.ygyno.2007.08.061. Epub 2007 Oct 25. Gynecol Oncol. 2008. PMID: 17915300 Clinical Trial.
61 results